Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations.

ABSTRACT: Treatments used for rheumatoid arthritis (RA) are under investigation for their efficacy to prevent RA in at risk groups. It is therefore important to understand treatment preferences of those at risk. We systematically reviewed quantitative preference studies of drugs to treat, or prevent RA, to inform the design of further studies and trials of RA prevention. Stated preference studies for RA treatment or prevention were identified through a search of five databases. Study characteristics and results were extracted, and the relative importance of different types of treatment attributes was compared across populations. Twenty three studies were included 20 of RA treatments (18 of patients; 2 of the general public) and 3 prevention studies with first-degree relatives (FDRs). Benefits, risks

SUBMITTER: Simons G 

PROVIDER: S-EPMC8862509 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature